AKT1 and breast cancer: This study also showed that the enhanced dephosphorylation of MAPK and Akt along with the upregulation of Caspase-3 following treatment with AZ628-loaded NPs might be persuasive to inhibit the uncontrolled cancer cell proliferation and thus improve the patient outcome in breast cancer treatment.